Chitinase 3-like protein 1: a diagnostic biomarker for early liver fibrosis in autoimmune liver diseases

Chitinase 3-like protein 1: a diagnostic biomarker for early liver fibrosis in autoimmune liver diseases

Background and AimsChitinase 3-like protein 1 (CHI3L1) is a marker of liver fibrosis produced mainly by hepatic macrophages. However, few studies have assessed the relationship between CHI3L1 and liver fibrosis in autoimmune liver diseases (AILDs). We aimed to explore the diagnostic value of CHI3L1...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shafei Liu, Conggao Peng, Shijia Xia, Chaonan Li, Xiahong Dai, Xingyu Liu, Meng Zhang, Xiaoping Li, Lingling Tang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-04-01
Series:	Frontiers in Immunology
Subjects:	chitinase 3 like protein 1 liver fibrosis autoimmune liver diseases chronic HBV fibroscan
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1504066/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The feasibility of using liver function indices and FibroScan in combination to predict the occurrence of anti-tuberculosis drug-induced liver injury in Patients with liver disease
by: Shaoqiang Wu, et al.
Published: (2025-01-01)

Liver stiffness and serum galectin 3 level significantly increases in patients with prediabetes: a fibroscan study
by: Huseyin Ali Ozturk, et al.
Published: (2025-04-01)

Liver steatosis is positively associated with plasminogen activator inhibitor-1 in apparently healthy individuals with overweight and obesity: A FibroScan-Based Cross-Sectional study
by: Giuseppe Lisco, et al.
Published: (2025-04-01)

An Assessment of the Feasibility, Patient Acceptance, and Performance of Point-of-Care Transient Elastography for Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD): A Systematic Review and Meta-Analysis
by: Taranika Sarkar Das, et al.
Published: (2024-11-01)

Prevalence of advanced liver fibrosis in the general population of the Paris region according to FIB-4 score and liver risk score
by: Henri Tran, et al.
Published: (2025-07-01)

Usefulness of pemafibrate for non-alcoholic fatty liver disease with hypertriglyceridemia
by: Masahiro Kikuchi, et al.
Published: (2024-09-01)

Role of chitinase-3-like protein 1 in liver diseases: A comprehensive review
by: Chao Tian, et al.
Published: (2025-11-01)

Diagnostic performance of FibroTouch® in assessing hepatic steatosis and fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: An Asian experience
by: Thanikan Sukaram, et al.
Published: (2025-01-01)

Liver stiffness measurement trajectory analysis for prognosis in patients with chronic hepatitis B and compensated advanced chronic liver disease
by: Hao Jiang, et al.
Published: (2025-01-01)

Molecular biology of microbial chitinase
by: FENG Jun-li, et al.
Published: (2004-01-01)

Innovative Elastography Measuring Cap for Ex Vivo Liver Condition Assessment: Numerical and Preclinical Studies in a Porcine Model
by: Dariusz Pyka, et al.
Published: (2025-01-01)

Liver damage in patients hospitalized with acute decompensated heart failure, depending on the degree of glucose metabolism disorder
by: V. V. Tolkacheva, et al.
Published: (2024-10-01)

The importance of elastography in hepatological diagnostics in children
by: Eliza Łężyk-Ciemniak, et al.
Published: (2025-03-01)

COMPARATIVE RESULTS OF LIVER TRANSPLANTATION IN PATIENTS WITH VIRAL CIRRHOSIS AND AUTOIMMUNE LIVER DISEASES AT A SINGLE CENTER
by: O.A Gerasimova, et al.
Published: (2012-03-01)

Autoimmune Haemolytic Anaemia in Patients With Chronic Liver Disease: Case Series
by: Dorien Pint, et al.
Published: (2025-04-01)

Thirteen-Year Follow-Up of a Patient with Liver Cirrhosis Resulting from the Overlap Syndrome of Autoimmune Hepatitis and Primary Biliary Cholangitis: Severe COVID-19 and Liver Transplantation
by: A. Kh. Odintsova, et al.
Published: (2024-03-01)

Recurrence of autoimmune hepatitis cholestatic variant syndromes after liver transplantation affects graft and patient survival
by: Vincenzo Ronca, et al.
Published: (2025-05-01)

Autoimmune liver diseases and systemic rheumatic disorders: exploring their interplay and impact on prognosis
by: Mohammad Egbaria, et al.
Published: (2025-04-01)

Identification of new diagnostic targets for hepatitis B virus‐induced liver fibrosis
by: Ying Wang, et al.
Published: (2024-03-01)

A case of reactive lymphoid hyperplasia of the liver in a patient with autoimmune hepatitis
by: Hiroki Kanno, et al.
Published: (2020-05-01)

SOME THEORETICAL ASPECTS OF COMPLEX CLINICAL-PSYCHOLOGICAL INVESTIGATION OF PATIENTS WITH AUTOIMMUNE LIVER DISEASES IN CIRRHOTIC STAGE BEFORE LIVER TRANSPLANTATION
by: O. A. Gerasimova, et al.
Published: (2010-06-01)

Effect of SARS-CoV-2 infection on liver function in patients with hepatitis B
by: Tong Sun, et al.
Published: (2024-12-01)

Study on the character of chitinase produced by Trichoderma spp. with measuring reducing sugar
by: LIU Kai-qi, et al.
Published: (2004-07-01)

Readily Available Index of Insulin Sensitivity Is Associated with Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis in Patients with Type 2 Diabetes
by: Stefano Ciardullo, et al.
Published: (2025-06-01)

Are mycoparasitism and chitinase production species or isolate dependent in Trichoderma?
by: Szakacs G, et al.
Published: (2004-07-01)

Assessment of hepatic fibrosis in patients with rheumatoid arthritis on long-term methotrexate therapy using transient elastography
by: Abhishek Kumar, et al.
Published: (2018-01-01)

Diagnostic options of non-invasive assessment of fibrosis at diffuse liver diseases
by: I. Yu. Pirogova, et al.
Published: (2009-08-01)

Relapse of autoimmune diseases after liver transplantation
by: V. E. Syutkin, et al.
Published: (2022-12-01)

Dissecting the genetic basis and mechanisms underlying the associations between multiple extrahepatic factors and autoimmune liver diseases
by: Zheng Zhang, et al.
Published: (2025-06-01)

An exploratory machine learning model for predicting advanced liver fibrosis in autoimmune hepatitis patients: A preliminary study
by: Qinglin Wei, et al.
Published: (2025-01-01)

Immunological and clinical overlap between autoimmune gastritis and autoimmune liver diseases: a prospective cohort study
by: Sara Massironi, et al.
Published: (2025-07-01)

Informative value of laboratory markers in assessing the stage of liver fibrosis in children with type 1 autoimmune hepatitis
by: O. V. Kurbatova, et al.
Published: (2023-04-01)

LIVER TRANSPLANTATION AND HBV INFECTION
by: O. I. Andreytseva, et al.
Published: (2009-06-01)

Vaccination against viral hepatitis B in patients undergoing liver transplantation for hepatitis B-unassociated causes
by: V. E. Syutkin, et al.
Published: (2018-08-01)

Correlation of Inflammatory Bowel Diseases with Liver Involvement Severity in Autoimmune Hepatobiliary Pathology: Cross-Sectional Study
by: Olga V. Usoltseva, et al.
Published: (2022-05-01)

Evaluation of four chatbots in autoimmune liver disease: A comparative analysis
by: Jimmy Daza, et al.
Published: (2025-01-01)

FATTY LIVER DISEASE: SOME CHALLENGES OF STEATOMETRY (REVIEW)
by: Olga V. Kovaleva, et al.
Published: (2025-04-01)

Regulatory T cell therapy in autoimmune liver disease and transplantationKeypoints
by: Maegen Fleming, et al.
Published: (2025-08-01)

Hepatic encephalomyelopathy: a complication following liver cirrhosis caused by Budd-Chiari syndrome and HBV
by: Jun Cheng, et al.
Published: (2014-04-01)

Liver and obesity: a narrative review
by: Amedeo Lonardo, et al.
Published: (2025-06-01)